Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 1/20 | 0.36 |
| ▸ | FEN1 | P39748 | 1/20 | 0.36 |
| ▸ | XDH | P47989 | 2/20 | 0.35 |
| ▸ | AR | P10275 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.31 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.31 |
| ▸ | BCAT1 | P54687 | 1/20 | 0.30 |
| ▸ | HRH1 | P35367 | 1/20 | 0.30 |
| ▸ | HTR6 | P50406 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22985225 | 0.97 | ALOX5AP (0.35) | ALOX5APFEN1XDHARTSHR | |
| SCHEMBL21399449 | 0.95 | AR (0.36) | ALOX5APFEN1XDHARTSHR | |
| SCHEMBL22985521 | 0.95 | ALOX5AP (0.39) | ALOX5APFEN1XDHARTSHR | |
| SCHEMBL22985546 | 0.93 | AR (0.38) | ALOX5APFEN1XDHARTSHR | |
| SCHEMBL21399450 | 0.92 | AR (0.36) | ALOX5APFEN1XDHARTSHR | |
| SCHEMBL22985621 | 0.92 | AR (0.42) | ALOX5APFEN1XDHARTSHR | |
| SCHEMBL22985625 | 0.92 | AR (0.43) | ALOX5APFEN1XDHARTSHR | |
| SCHEMBL22985511 | 0.91 | ALOX5AP (0.36) | ALOX5APFEN1XDHARTSHR | |
| SCHEMBL20849225 | 0.91 | AR (0.35) | XDHAR | |
| SCHEMBL22985224 | 0.91 | ALOX5AP (0.35) | ALOX5APFEN1XDHARTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10919880-B2 | Organic molecules, in particular for use in optoelectronic devices | CYNORA GMBH (DE) | 2021-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10919880-B2 | Organic molecules, in particular for use in optoelectronic devices | OCIAD1, OCIAD2, POU2F1 | ALOX5AP 2567/4885FEN1 2939/4885XDH 1167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.